UCP1 and metabolic disease: Indeed, previous studies suggest that therapeutic strategies aimed at increasing UCP1 expression, using synthetic and natural bioactive compounds, could be an effective approach to promote adipocyte browning and eventually combat metabolic diseases such as obesity [12,87,88,89,90].